Review



6c8g7  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Novus Biologicals 6c8g7
    6c8g7, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/6c8g7/product/Novus Biologicals
    Average 93 stars, based on 2 article reviews
    6c8g7 - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    6c8g7  (Novus Biologicals)
    93
    Novus Biologicals 6c8g7
    6c8g7, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/6c8g7/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    6c8g7 - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    eph receptor a7 6c8g7  (Novus Biologicals)
    90
    Novus Biologicals eph receptor a7 6c8g7
    Immunohistochemical (IHC) staining for <t>EPHA7</t> in relation to myoferlin expression and prognosis in clear cell renal cell carcinoma. ( a ) The IHC staining level of EPHA7 was similar between myoferlin-high and myoferlin-low cancers, ( b ) high EPHA7 expression (score 8, strong expression in 67–100%), ( c ) low EPHA7 expression (score 2, weak expression in 0–1%), ( d ) progression-free survival, ( e ) overall survival, and ( f ) cancer-specific survival. Scale bar = 100 μm.
    Eph Receptor A7 6c8g7, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eph receptor a7 6c8g7/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    eph receptor a7 6c8g7 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Immunohistochemical (IHC) staining for EPHA7 in relation to myoferlin expression and prognosis in clear cell renal cell carcinoma. ( a ) The IHC staining level of EPHA7 was similar between myoferlin-high and myoferlin-low cancers, ( b ) high EPHA7 expression (score 8, strong expression in 67–100%), ( c ) low EPHA7 expression (score 2, weak expression in 0–1%), ( d ) progression-free survival, ( e ) overall survival, and ( f ) cancer-specific survival. Scale bar = 100 μm.

    Journal: Cancers

    Article Title: c-Met and EPHA7 Receptor Tyrosine Kinases Are Related to Prognosis in Clear Cell Renal Cell Carcinoma: Focusing on the Association with Myoferlin Expression

    doi: 10.3390/cancers14041095

    Figure Lengend Snippet: Immunohistochemical (IHC) staining for EPHA7 in relation to myoferlin expression and prognosis in clear cell renal cell carcinoma. ( a ) The IHC staining level of EPHA7 was similar between myoferlin-high and myoferlin-low cancers, ( b ) high EPHA7 expression (score 8, strong expression in 67–100%), ( c ) low EPHA7 expression (score 2, weak expression in 0–1%), ( d ) progression-free survival, ( e ) overall survival, and ( f ) cancer-specific survival. Scale bar = 100 μm.

    Article Snippet: The following RTKs and ligands were examined using IHC staining: c-Met (ready-to-use, SP44, Ventana, Tucson, AZ, USA), Eph receptor A7 (EPHA7; 1:800, 6C8G7, Novus Biologicals, Centennial, CO, USA), HER2 (ready-to-use, 4B5, Ventana), hepatocyte growth factor (HGF; 1:100, ab118871, Abcam, Cambridge, UK), VEGFA (1:300, sc-7261, Santa Cruz Biotechnology, Dallas, TX, USA), and ephrin A5 (EFNA5; 1:100, LS-C356004, Lifespan Biosciences, Seattle, WA, USA).

    Techniques: Immunohistochemical staining, Immunohistochemistry, Expressing

    Survival of clear cell renal cell carcinoma patients analyzed by Cox regression including EPHA7, TNM stage, and WHO grade.

    Journal: Cancers

    Article Title: c-Met and EPHA7 Receptor Tyrosine Kinases Are Related to Prognosis in Clear Cell Renal Cell Carcinoma: Focusing on the Association with Myoferlin Expression

    doi: 10.3390/cancers14041095

    Figure Lengend Snippet: Survival of clear cell renal cell carcinoma patients analyzed by Cox regression including EPHA7, TNM stage, and WHO grade.

    Article Snippet: The following RTKs and ligands were examined using IHC staining: c-Met (ready-to-use, SP44, Ventana, Tucson, AZ, USA), Eph receptor A7 (EPHA7; 1:800, 6C8G7, Novus Biologicals, Centennial, CO, USA), HER2 (ready-to-use, 4B5, Ventana), hepatocyte growth factor (HGF; 1:100, ab118871, Abcam, Cambridge, UK), VEGFA (1:300, sc-7261, Santa Cruz Biotechnology, Dallas, TX, USA), and ephrin A5 (EFNA5; 1:100, LS-C356004, Lifespan Biosciences, Seattle, WA, USA).

    Techniques: